Pembina Pipeline
PBA
45.97
-0.74
-1.58%
Pembina Pipeline
US · PBA
#762 by market cap
Listed 1970
45.97
-0.74
-1.58%
Live - 5344 symbols - heartbeat 404s ago
· 2026-10-08 07:38
Pre-market
44.59
-3.00%
After-hours
45.97
0.00%
- Market cap
- 26.73B
- P/E (TTM)i
- 23.08
- P/Bi
- 2.48
- EPSi
- 1.87
- Div yieldi
- 4.39%
- 52W posi
- 69%
Reader sentiment
Are you bullish or bearish on PBA?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.20, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +5.34% YoY
Margins
- Gross margin
- 41.05%
- Operating margin
- 34.66%
- Net margin
- 19.93%
Key ratios & quality
- Enterprise valuei
- 39.40B
- Altman Z-Scorei
- 1.20
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.35B | 6.37B | 5.95B | 8.63B | 11.61B | 6.33B | 7.38B | 7.78B |
| Gross profit | 2.33B | 2.44B | 2.01B | 2.65B | 3.12B | 2.84B | 3.32B | 3.19B |
| Selling & admin expenses | 279.00M | 296.00M | 246.00M | 306.00M | 399.00M | 422.00M | 444.00M | 477.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.02B | 2.13B | 1.78B | 2.59B | 2.60B | 2.42B | 2.88B | 2.70B |
| Pretax profit | 1.74B | 1.54B | -416.00M | 1.67B | 3.22B | 2.19B | 1.72B | 2.21B |
| Tax | 464.00M | 35.00M | -100.00M | 423.00M | 248.00M | 413.00M | -154.00M | 513.00M |
| Net profit | 1.28B | 1.51B | -316.00M | 1.24B | 2.97B | 1.78B | 1.87B | 1.69B |
| Basic EPS | 2 | 3 | -1 | 2 | 5 | 3 | 3 | 3 |
| Diluted EPS | 2.28 | 2.68 | -0.86 | 1.99 | 5.12 | 2.99 | 3.00 | 2.66 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 2.28B | 1.79B | 1.79B | 1.91B | 2.11B | 2.15B |
| Gross profit | 928.00M | 780.00M | 658.00M | 827.00M | 929.00M | 933.00M |
| Selling & admin expenses | 134.00M | 97.00M | 126.00M | 120.00M | 142.00M | 132.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 789.00M | 684.00M | 551.00M | 672.00M | 786.00M | 806.00M |
| Pretax profit | 639.00M | 533.00M | 398.00M | 637.00M | 631.00M | 652.00M |
| Tax | 137.00M | 116.00M | 112.00M | 148.00M | 133.00M | 140.00M |
| Net profit | 502.00M | 417.00M | 286.00M | 489.00M | 498.00M | 512.00M |
| Basic EPS | 1 | 1 | 0 | 1 | 1 | 1 |
| Diluted EPS | 0.80 | 0.65 | 0.43 | 0.78 | 0.80 | 0.82 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.01B | 989.00M | 989.00M | 1.25B | 1.36B | 2.63B | 1.57B | 1.26B |
| Cash & ST investments | 157.00M | 129.00M | 81.00M | 43.00M | 94.00M | 137.00M | 141.00M | 106.00M |
| Inventory | 198.00M | 126.00M | 221.00M | 376.00M | 269.00M | 333.00M | 301.00M | 284.00M |
| Total assets | 26.81B | 32.76B | 31.42B | 31.46B | 31.49B | 32.62B | 35.97B | 35.56B |
| Total current liabilities | 1.54B | 1.45B | 1.78B | 2.39B | 2.06B | 3.22B | 2.91B | 2.07B |
| Short-term debt | 536.00M | 186.00M | 699.00M | 1.09B | 679.00M | 727.00M | 1.61B | 683.00M |
| Long-term debt | 7.05B | 10.08B | 10.28B | 10.24B | 10.00B | 9.85B | 11.13B | 12.09B |
| Total liabilities | 12,302,000,000.00 | 15,887,000,000.00 | 16,401,000,000.00 | 17,093,000,000.00 | 15,698,000,000.00 | 16,805,000,000.00 | 18,457,000,000.00 | 18,784,000,000.00 |
| Total equity | 14.51B | 16.87B | 15.02B | 14.36B | 15.79B | 15.81B | 17.51B | 16.77B |
| Retained earnings | -1.95B | -1.79B | -3.64B | -3.92B | -2.61B | -2.37B | -2.30B | -2.38B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.41B | 1.38B | 1.34B | 1.26B | 1.71B | 1.57B |
| Cash & ST investments | 155.00M | 210.00M | 149.00M | 106.00M | 173.00M | 153.00M |
| Inventory | 253.00M | 275.00M | 304.00M | 284.00M | 324.00M | 297.00M |
| Total assets | 35.71B | 35.42B | 35.45B | 35.56B | 36.17B | 36.24B |
| Total current liabilities | 2.21B | 1.78B | 2.50B | 2.07B | 2.05B | 2.54B |
| Short-term debt | 1.06B | 679.00M | 1.18B | 683.00M | 681.00M | 1.28B |
| Long-term debt | 11.52B | 12.14B | 11.54B | 12.09B | 12.71B | 12.01B |
| Total liabilities | 18,140,000,000.00 | 18,385,000,000.00 | 18,444,000,000.00 | 18,784,000,000.00 | 19,275,000,000.00 | 19,177,000,000.00 |
| Total equity | 17.57B | 17.04B | 17.00B | 16.77B | 16.90B | 17.06B |
| Retained earnings | -2.24B | -2.27B | -2.43B | -2.38B | -2.33B | -2.27B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.26B | 2.53B | 2.25B | 2.65B | 2.93B | 2.64B | 3.21B | 3.30B |
| Depreciation & amortization | 417.00M | 507.00M | 700.00M | 723.00M | 683.00M | 663.00M | 862.00M | 987.00M |
| Free cash flow | 1.03B | 887.00M | 1.22B | 1.99B | 2.32B | 2.03B | 2.26B | 2.52B |
| Dividends paid | -1.25B | -1.32B | -1.53B | -1.52B | -1.65B | -1.58B | -1.70B | -1.77B |
| Stock buybacks / issuance | -- | -- | 0 | -17.00M | -333.00M | -50.00M | -- | -- |
| Ending cash balance | 157.00M | 129.00M | 81.00M | 43.00M | 107.00M | 151.00M | 141.00M | 106.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 840.00M | 790.00M | 810.00M | 861.00M | 335.00M | 897.00M |
| Depreciation & amortization | 233.00M | 257.00M | 241.00M | 256.00M | 230.00M | 245.00M |
| Free cash flow | 666.00M | 593.00M | 632.00M | 626.00M | 148.00M | 679.00M |
| Dividends paid | -436.00M | -447.00M | -445.00M | -444.00M | -443.00M | -457.00M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 155.00M | 210.00M | 149.00M | 106.00M | 173.00M | 153.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 9.90 | 10.60 | -3.70 | 9.23 | 22.46 | 12.15 | 11.89 | 10.20 |
| ROA %i | 4.42 | 4.55 | -1.47 | 3.49 | 9.03 | 5.14 | 5.02 | 4.33 |
| ROIC %i | 7.10 | 7.58 | -0.66 | 6.02 | 13.47 | 8.19 | 8.19 | 7.06 |
| 5-year avg ROE %i | 7.50 | 8.26 | 6.32 | 6.97 | 9.70 | 10.16 | 10.41 | 13.18 |
| EBIT margin %i | 27.59 | 25.57 | 0.00 | 24.40 | 31.70 | 29.14 | 31.35 | 36.24 |
| FCF / sales %i | 14.01 | 12.27 | 19.72 | 23.09 | 20.02 | 22.24 | 30.59 | 32.36 |
| Current ratioi | 0.66 | 0.68 | 0.56 | 0.52 | 0.66 | 0.82 | 0.54 | 0.61 |
| Quick ratioi | 0.50 | 0.55 | 0.40 | 0.34 | 0.46 | 0.68 | 0.42 | 0.45 |
| Debt / assetsi | 29.83 | 33.49 | 37.08 | 38.03 | 35.81 | 34.16 | 37.04 | 37.44 |
| LT debt / equityi | 62.05 | 77.86 | 91.19 | 92.26 | 78.37 | 76.51 | 76.29 | 83.95 |
| Interest coveragei | 7.09 | 5.76 | 0.00 | 4.78 | 7.97 | 5.66 | 3.89 | 4.61 |
| Revenue CAGR (3Y) %i | 16.62 | 14.32 | 3.30 | 5.48 | 22.14 | 2.07 | -5.05 | -12.50 |
| Net income CAGR (3Y) %i | 46.56 | 47.88 | -- | -0.95 | 25.39 | -- | 14.49 | -17.08 |
| FCF CAGR (3Y) %i | -- | -- | -- | 24.59 | 37.86 | 18.38 | 4.28 | 2.69 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 12.25 | 11.49 | 10.94 | 10.20 | 10.11 | 10.79 |
| ROA %i | 5.18 | 4.87 | 4.61 | 4.33 | 4.30 | 4.58 |
| ROIC %i | 8.46 | 7.73 | 7.42 | 7.06 | 6.97 | 7.32 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 30.09 | 37.24 | 36.55 | 36.24 | 37.00 | 36.91 |
| FCF / sales %i | 32.92 | 31.99 | 31.85 | 32.36 | 26.30 | 26.19 |
| Current ratioi | 0.64 | 0.77 | 0.53 | 0.61 | 0.83 | 0.62 |
| Quick ratioi | 0.51 | 0.61 | 0.41 | 0.45 | 0.67 | 0.49 |
| Debt / assetsi | 36.80 | 37.76 | 37.49 | 37.44 | 38.47 | 38.10 |
| LT debt / equityi | 78.38 | 84.19 | 80.51 | 83.95 | 87.23 | 81.66 |
| Interest coveragei | 3.98 | 4.90 | 4.77 | 4.61 | 4.58 | 4.73 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Marketing & New Ventures is the largest reported line at 57.99% of revenue, across 4 reported segments.
- Pipelines follows at 39.59%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Marketing & New Ventures57.99%
Pipelines39.59%
Facilities14.59%
Quote time 2026-10-08 07:38:41 · For reference only, not investment advice and not tailored to your situation.